EastWest Bioscience Inc.
HBOSF · OTC
4/30/2022 | |
|---|---|
| Revenue | $200 |
| % Growth | – |
| Cost of Goods Sold | $56 |
| Gross Profit | $144 |
| % Margin | 71.9% |
| R&D Expenses | $0 |
| G&A Expenses | $358 |
| SG&A Expenses | $361 |
| Sales & Mktg Exp. | $3 |
| Other Operating Expenses | $0 |
| Operating Expenses | $285 |
| Operating Income | -$141 |
| % Margin | -70.5% |
| Other Income/Exp. Net | -$43 |
| Pre-Tax Income | -$184 |
| Tax Expense | $252 |
| Net Income | -$436 |
| % Margin | -218.2% |
| EPS | -0.004 |
| % Growth | – |
| EPS Diluted | -0.004 |
| Weighted Avg Shares Out | 100,664 |
| Weighted Avg Shares Out Dil | 100,664 |
| Supplemental Information | – |
| Interest Income | $0 |
| Interest Expense | $56 |
| Depreciation & Amortization | $19 |
| EBITDA | -$390 |
| % Margin | -195.2% |